Xbira 250 mg Tablet 120s
MRP: ₹28,500.00
Packaging
1 TAB
Composition
Abirateron 250mg
Company
CIPLA
MRP: ₹28,500.00
Packaging
1 TAB
Composition
Abirateron 250mg
Company
CIPLA
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Abatitor 250mg Tablet 30s | Torrent Pharma | ₹9,900.00 | Save ₹18,600.00 |
| Abatitor 250mg Tablet 60s | Torrent Pharma | ₹19,900.00 | Save ₹8,600.00 |
| Zelgor 250 mg Tablet 120s | Sun Pharma | ₹25,000.00 | Save ₹3,500.00 |
| Abirapro 250 mg Tablet 120s | Glenmark | ₹28,000.00 | Save ₹500.00 |
| Celbira 250mg Tablet 120s | Celon Labs | ₹28,000.00 | Save ₹500.00 |
| Zecyte 250mg Tablet 120s | Cipla | ₹28,500.00 | — |
| Samtica 250mg Tablet 120s | Samarth Pharma | ₹29,700.00 | — |
| Abiracure 250mg Tablet 120s | Emcure Pharma | ₹29,900.00 | — |
| Zytiprost 250mg Tablet 120s | Alkem Labs | ₹34,200.00 | — |
| Abitate U Tablet 120s | RPG Life Sciences | ₹39,000.00 | — |
| Arbitus 250mg Tablet 120s | Dr. Reddy | ₹39,500.00 | — |
| Abatitor 250mg Tablet 120s | Torrent Pharma | ₹39,900.00 | — |
| Abstet 250mg Tablet 120s | Biocon Ltd | ₹39,900.00 | — |
| Alkeprost 250mg Tablet 120s | Alkem Labs | ₹45,000.00 | — |
Abiraterone is used in the treatment of metastatic castration-resistant prostate cancer.
Side effects of Abirateron may include Urinary tract infection,Hypokalemia, Hypertension Diarrhoea etc.
Abiraterone is a CYP3A4 substrate and hence should not be administered in patients concurrently on strong CYP3A4 inhibitors or inducers.Likewise it inhibits CYP1A2, CYP2C9 and CYP3A4 and hence should not be given to patients concurrently being treated with substrates of any of these enzymes that have a narrow therapeutic index.
Patients with severe baseline hepatic , impairment , Mineralocorticoid excess , cardiovascular disease, including heart failure and hypertension, uncorrected hypokalaemia , adrenocorticoid insufficiency and Hepatotoxicity that may result from treatment with abiraterone
Abiraterone inhibits 17 α-hydroxylase/C17,20 lyase (CYP17A1), an enzyme which is expressed in testicular, adrenal, and prostatic tumor tissues. CYP17 catalyzes two sequential reactions: (a) the conversion of pregnenolone and progesterone to their 17-α-hydroxy derivatives by its 17 α-hydroxylase activity, and (b) the subsequent formation of dehydroepiandrosterone (DHEA) and androstenedione, respectively, by its C17,20 lyase activity. DHEA and androstenedione are androgens and precursors of testosterone. Inhibition of CYP17 activity by abiraterone thus decreases circulating levels of testosterone.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| 8X Shampoo 100ml | Bottle | ₹273.35 |
| 8X Shampoo 60ml | Bottle | ₹0.00 |
| 9PM Eye Drop 2.5ml | Eye Drop | ₹518.95 |
| Abamune 300 mg Tablet 30s | TAB | ₹1,487.14 |
| Abamune-L Tablet 30s | TAB | ₹2,778.38 |
| Ablung 100mg Capsule 10s | CAP | ₹93.77 |
| Ablung 200mg Capsule 10s | CAP | ₹197.00 |
| Acemax 250mg Tablet 100s | TAB | ₹36.91 |
| Acivir 200 mg DT Tablet 10s | TAB | ₹71.22 |
| Acivir 25 mg Injection | INJECTION | ₹361.10 |
| Acivir 400 mg DT Tablet 5s | TAB | ₹64.68 |
| Acivir 500 Infusion | INJECTION | ₹502.58 |
| Acivir Cream 5gm | CREAM | ₹59.95 |
| Acivir DT 800 mg Tablet 5s | TAB | ₹185.00 |
| Acivir Eye Ointment 5gm | Eye Drop | ₹52.90 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist